We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Molly Coddington

Molly Coddington profile page

Senior Writer and Newsroom Team Lead

 at Technology Networks


Molly reports on various scientific topics, covering the latest breaking news and writing long-form pieces. In 2020, she created the Teach Me in 10 video series, where weekly guests discuss and teach a scientific concept in less than 10 minutes. Before joining Technology Networks in 2019, Molly worked as a clinical research associate in the NHS and as a freelance science writer. She has a first-class honors degree in neuroscience from the University of Leeds and received a Partnership Award for her efforts in science communication.


Education


University of Leeds  


Awards & Certifications


Georgina Henry Award for Digital Innovation Nominee

Lord Laidlaw Scholarship Recipient, University of Leeds

Partnership Award, University of Leeds


Accreditations


Neuroscience, BSc (Hons) recognised by the University of Leeds


Areas of Expertise



Got a Question for Molly Coddington?


Get in touch using the contact form linked here and we’ll get back to you shortly.



Published Content
Total: 913
News

New Study of HIV Vaccine Shows Promising Results Across Strains

Using the same RV 144 HIV vaccine employed in Thailand, a new study has evaluated whether the vaccine-induced immune responses to RV 144 are similar in a South African cohort.
Industry Insight

Talking Clinical Proteomics With Dr Roman Fischer

Technology Networks spoke with Dr Roman Fischer to learn more about the challenges researchers face in the field of clinical proteomics, and how 4D proteomics workflows are enhancing his laboratory's work.
Exploring the Fourth Dimension of Proteome Analysis content piece image
Industry Insight

Exploring the Fourth Dimension of Proteome Analysis

Recent developments in MS technology have enabled a fourth dimension of analysis: ion mobility separation. The term "4D proteomics" has been created to describe analysis that incorporates all four dimensions. We interviewed two researchers at the forefront of the proteomics field to learn more about how 4D proteomics approaches are enhancing their research.


Penguin Genome Consortium Glean Insights Into Life on Ice content piece image
News

Penguin Genome Consortium Glean Insights Into Life on Ice

In a study published today in GigaScience, the Penguin Genome Consortium has produced 19 high-coverage penguin genome sequences. Coupled with two previously published genomes, these sequences encompass all surviving penguin species.
UK BioBank Project Is Taken to the Next Level by Sequencing 500,000 Genomes content piece image
Article

UK BioBank Project Is Taken to the Next Level by Sequencing 500,000 Genomes

In a bid to push personalized medicine forward, an ambitious ground-breaking £200 million project will see the 500,000 BioBank participants' whole genomes sequenced.
Novel Gene Therapy Is Successful in Improving Functional Recovery After Stroke content piece image
News

Novel Gene Therapy Is Successful in Improving Functional Recovery After Stroke

In a mouse model of stroke, researchers successfully pioneer a new gene therapy developed to turn glial cells into neurons.
News

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

In a world first, researchers from Penn Medicine have used genetically modified T cells to target and ablate fibroblasts that contribute to the development of heart disease.
News

Researchers Crack the Conundrum of Why We Gain Weight As We Get Older

In a new study, researchers have identified why we gain weight as we get older - decreased lipid turnover.
Industry Insight

Harnessing the Power of Proteins To Unlock Cell and Gene Therapies

We recently spoke with Paul Wotton, Ph.D., CEO at Obsidian Therapeutics, to gain his insights on the genetically engineered cell-therapy research area, and to learn how Obsidian Therapeutics' cytoDRiVE platform can increases the specificity and safety of such therapies.
News

CRISPR-Chip Moves One Step Closer to the Genomics Market

Cardea Bio and Nanosens Innovations have announced that they will be joining forces. We recently spoke with Michael Heltzen, Cardea Bio CEO (and Nanosens co-founder) to learn more about the merger.
Advertisement